Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1

被引:152
作者
Chau, BN
Cheng, EHY
Kerr, DA
Hardwick, JM [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Publ Hlth, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Publ Hlth, Dept Neurol, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S1097-2765(00)00005-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bcl-x(L), an antiapoptotic Bcl-2 family member, is postulated to function at multiple stages in the cell death pathway. The possibility that Bcl-x(L) inhibits cell death at a late (postmitochondrial) step in the death pathway is supported by this report of a novel apoptosis inhibitor, Aven, which binds to both Bcl-x(L) and the caspase regulator, Apaf-1. Identified in a yeast two-hybrid screen, Aven is broadly expressed and is conserved in other mammalian species. Only those mutants of Bcl-x(L) that retain their antiapoptotic activity are capable of binding Aven. Aven interferes with the ability of Apaf-1 to self-associate, suggesting that Aven impairs Apaf-1-mediated activation of caspases. Consistent with this idea, Aven inhibited the proteolytic activation of caspases in a cell-free extract and suppressed apoptosis induced by Apaf-1 plus caspase-9. Thus, Aven represents a new class of cell death regulator.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 55 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins [J].
Bellows, DS ;
Chau, BN ;
Lee, P ;
Lazebnik, Y ;
Burns, WH ;
Hardwick, JM .
JOURNAL OF VIROLOGY, 2000, 74 (11) :5024-5031
[3]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[4]   Apaf-1 oligomerizes into biologically active ∼700-kDa and inactive ∼1.4-MDa apoptosome complexes [J].
Cain, K ;
Bratton, SB ;
Langlais, C ;
Walker, G ;
Brown, DG ;
Sun, XM ;
Cohen, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) :6067-6070
[5]   Caspase activation involves the formation of the aposome, a large (∼700 kDa) caspase-activating complex [J].
Cain, K ;
Brown, DG ;
Langlais, C ;
Cohen, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22686-22692
[6]   Identification of a novel regulatory domain in Bcl-x(L) and Bcl-2 [J].
Chang, BS ;
Minn, AJ ;
Muchmore, SW ;
Fesik, SW ;
Thompson, CB .
EMBO JOURNAL, 1997, 16 (05) :968-977
[7]   A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak [J].
Cheng, EHY ;
Nicholas, J ;
Bellows, DS ;
Hayward, GS ;
Guo, HG ;
Reitz, MS ;
Hardwick, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :690-694
[8]   Bax-independent inhibition of apoptosis by Bcl-x(L) [J].
Cheng, EHY ;
Levine, B ;
Boise, LH ;
Thompson, CB ;
Hardwick, JM .
NATURE, 1996, 379 (6565) :554-556
[9]   Conversion of Bcl-2 to a Bax-like death effector by caspases [J].
Cheng, EHY ;
Kirsch, DG ;
Clem, RJ ;
Ravi, R ;
Kastan, MB ;
Bedi, A ;
Ueno, K ;
Hardwick, JM .
SCIENCE, 1997, 278 (5345) :1966-1968
[10]   Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death [J].
Chinnaiyan, AM ;
ORourke, K ;
Lane, BR ;
Dixit, VM .
SCIENCE, 1997, 275 (5303) :1122-1126